.png){kind=logo}
GC Asia
Keryx aims for dual listing on high-growth exchanges
WESTLB and Roth Capital should complete the first simultaneous Nasdaq and Aim listing next week.
The $46m-$55m IPO of Keryx Biopharmaceuticals was due to close on Tuesday, but has been postponed and will be completed imminently, a banker close
to the deal said. The deal
...
Please take a trial or subscribe to access this content.
Contact our subscriptions team to discuss your access: subs@globalcapital.com
Or sign up for a trial to gain full access to the entire site for a limited period.
Corporate access
To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.
-
Latest news from Equity
-
Hard-hit firms mull market rescues as governments change support goalposts
07 Apr 2020 -
Investors rush to support WH Smith Covid-19 raise
07 Apr 2020 -
Secondary blocks market thaws with large AB InBev sale
07 Apr 2020 -
The coronavirus graphic to watch: first signs of Spain decelerating
07 Apr 2020 -
Bankers suggest secondary sell-downs to return
06 Apr 2020
-
-
Latest news from Equity
-
Hard-hit firms mull market rescues as governments change support goalposts
07 Apr 2020 -
Investors rush to support WH Smith Covid-19 raise
07 Apr 2020 -
Secondary blocks market thaws with large AB InBev sale
07 Apr 2020 -
The coronavirus graphic to watch: first signs of Spain decelerating
07 Apr 2020 -
Bankers suggest secondary sell-downs to return
06 Apr 2020
-
Further Reading
-
High Yield Bonds
Hard-hit firms mull market rescues as governments change support goalposts
-
Equity
Investors rush to support WH Smith Covid-19 raise
-
ABBs/Block Trades
Secondary blocks market thaws with large AB InBev sale
-
SRI / Green Bonds
The coronavirus graphic to watch: first signs of Spain decelerating
